UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.556

Sortiert nach

LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss

Cells (Basel, Switzerland), 2022-03, Vol.11 (5), p.861

2022

Volltextzugriff (PDF)

An early endosome regulator, Rab5b, is an LRRK2 kinase substrate

Journal of biochemistry (Tokyo), 2015-06, Vol.157 (6), p.485-495

2015

Volltextzugriff (PDF)

Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers

Experimental and Molecular Medicine, 2011, 43(4), , pp.216-222

2011

Volltextzugriff (PDF)

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Nature communications, 2013, Vol.4 (1), p.1562-1562, Article 1562

2013

Volltextzugriff (PDF)

Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission

The Journal of neuroscience, 2012-09, Vol.32 (39), p.13454-13469

2012

Volltextzugriff (PDF)

Nuclear α-Synuclein-Derived Cytotoxic Effect via Altered Ribosomal RNA Processing in Primary Mouse Embryonic Fibroblasts

International journal of molecular sciences, 2023-01, Vol.24 (3), p.2132

2023

Volltextzugriff (PDF)

Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein

Antioxidants & redox signaling, 2013-03, Vol.18 (7), p.770

2013

Volltextzugriff (PDF)

Expression of transduced nucleolin promotes the clearance of accumulated α-synuclein in rodent cells and animal model

Neurobiology of disease, 2021-07, Vol.154, p.105349, Article 105349

2021

Volltextzugriff (PDF)

Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors

Current issues in molecular biology, 2024-05, Vol.46 (5), p.4324-4336

2024

Volltextzugriff (PDF)

Dexamethasone induces the expression of LRRK2 and α-synuclein, two genes that when mutated cause Parkinson's disease in an autosomal dominant manner

BMB Reports, 2013, 46(9), , pp.454-459

2013

Volltextzugriff (PDF)

G2385R and I2020T Mutations Increase LRRK2 GTPase Activity

BioMed research international, 2016-01, Vol.2016, p.7917128-8

2016

Volltextzugriff (PDF)

G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses

Animal Cells and Systems, 2019, 23(2), , pp.106-111

2019

Volltextzugriff (PDF)

Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson’s Disease

Parkinson's disease, 2018-01, Vol.2018, p.1241757-9

2018

Volltextzugriff (PDF)

Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson's disease

Animal Cells and Systems, 2021, 25(1), , pp.28-36

2021

Volltextzugriff (PDF)

Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein

Cell cycle (Georgetown, Tex.), 2019-02, Vol.18 (4), p.467-475

2019

Volltextzugriff (PDF)

Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity

Animal Cells and Systems, 2018, 22(5), , pp.273-280

2018

Volltextzugriff (PDF)

Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression

Molecular brain, 2017-10, Vol.10 (1), p.48-48, Article 48

2017

Volltextzugriff (PDF)

Enzyme-linked immunosorbent assays for alpha-synuclein with species and multimeric state specificities

Journal of neuroscience methods, 2011-08, Vol.199 (2), p.249-257

2011

Volltextzugriff (PDF)

Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression

Molecular brain, 2015-09, Vol.8 (1), Article 54

2015

Volltextzugriff (PDF)

Dexamethasone induces the expression of LRRK2 and α-synuclein, two genes that when mutated cause Parkinson`s disease in an autosomal dominant manner

BMB reports, 2013-09, Vol.46 (9), p.454-459

2013

Volltextzugriff (PDF)

Increased DJ-1 in Urine Exosome of Korean Males with Parkinson’s Disease

BioMed research international, 2014-01, Vol.2014, p.704678-8

2014

Volltextzugriff (PDF)

LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells

Oxidative medicine and cellular longevity, 2021, Vol.2021 (1), p.9969842-9969842

2021

Volltextzugriff (PDF)

LRRK2 impairs autophagy by mediating phosphorylation of leucyl‐tRNA synthetase

Cell biochemistry and function, 2018-12, Vol.36 (8), p.431-442

2018

Volltextzugriff (PDF)

Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity

Biochemical and biophysical research communications, 2017-01, Vol.482 (4), p.1088-1094

2017

Volltextzugriff (PDF)

Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression

Molecular brain, 2015-09, Vol.8, p.54-54

2015

Volltextzugriff (PDF)

1 – 25 von 4.556

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.965)
Mit Volltextzugriff
(4.256)

Publikationsform

Sprache

Englisch
(3.828)
Koreanisch
(706)
Japanisch
(420)
Chinesisch
(4)
Spanisch
(2)
Deutsch
(1)
Russisch
(1)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.752)
Life Sciences & Biomedicine
(1.844)
Humans
(1.204)
Male
(875)
Female
(809)
Middle Aged
(684)
Technology
(653)
Physical Sciences
(579)
Aged
(523)
Adult
(469)
Materials Science
(349)
Retrospective Studies
(318)
Animals
(302)
Engineering
(296)
Physics
(294)
Chemistry
(291)
Treatment Outcome
(287)
Materials Science, Multidisciplinary
(275)
Original
(275)
Science & Technology - Other Topics
(268)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss

An early endosome regulator, Rab5b, is an LRRK2 kinase substrate

Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission

Nuclear α-Synuclein-Derived Cytotoxic Effect via Altered Ribosomal RNA Processing in Primary Mouse Embryonic Fibroblasts

Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein

Expression of transduced nucleolin promotes the clearance of accumulated α-synuclein in rodent cells and animal model

Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors

Dexamethasone induces the expression of LRRK2 and α-synuclein, two genes that when mutated cause Parkinson's disease in an autosomal dominant manner

G2385R and I2020T Mutations Increase LRRK2 GTPase Activity

G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses

Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson’s Disease

Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson's disease

Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein

Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity

Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression

Enzyme-linked immunosorbent assays for alpha-synuclein with species and multimeric state specificities

Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression

Dexamethasone induces the expression of LRRK2 and α-synuclein, two genes that when mutated cause Parkinson`s disease in an autosomal dominant manner

Increased DJ-1 in Urine Exosome of Korean Males with Parkinson’s Disease

LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells

LRRK2 impairs autophagy by mediating phosphorylation of leucyl‐tRNA synthetase

Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity

Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression

Suchergebnisse filtern